Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studies.
Li J, Kumar P, Anreddy N, Zhang YK, Wang YJ, Chen Y, Talele TT, Gupta K, Trombetta LD, Chen ZS.
Li J, et al. Among authors: chen zs, chen y.
Oncotarget. 2017 Sep 16;8(55):93785-93799. doi: 10.18632/oncotarget.21078. eCollection 2017 Nov 7.
Oncotarget. 2017.
PMID: 29212189
Free PMC article.